Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation

International Journal of Obesity

Volumn 40, Issue 10, 2016, Pages 1566-1573

  Ahmed, S ^a   Atlas, E ^a  

^a HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL S; CCAAT ENHANCER BINDING PROTEIN ALPHA; COMPLEMENT FACTOR D; DEXAMETHASONE; LIPID; LIPOPROTEIN LIPASE; LUCIFERASE; MESSENGER RNA; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENOL DERIVATIVE; ROSIGLITAZONE; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; SULFONE;

3T3 CELL LINE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; EMBRYO; LIPID STORAGE; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; TRANSCRIPTOMICS; UPREGULATION; 3T3-L1 CELL LINE; ADIPOCYTE; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION; METABOLISM; STEM CELL; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BENZHYDRYL COMPOUNDS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; MICE; PHENOLS; PPAR GAMMA; STEM CELLS; SULFONES;

EID: 84976274883     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.95     Document Type: Article

References (48)

1. Rubin B, Bisphenol A. An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011; 127: 27-34.
2. Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 2009; 117: 639-644.
3. Liao C, Liu F, Guo Y, Moon HB, Nakata H, Wu Q et al. Occurrence of eight bisphenol analogues in indoor dust from the United States and several Asian countries: implications for human exposure. Environ Sci Technol 2012; 46: 9138-9145.
4. Vandenberg LN, Chahoud I, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect 2010; 118: 1051-1054.
5. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004; 51: 165-169.
6. Ranciere F, Lyons JG, Loh VH, Botton J, Galloway T, Wang T et al. Bisphenol A and the risk of cardiometabolic disorders: A systematic review with meta-analysis of the epidemiological evidence. Environ Health 2015; 14: 46.
7. Watkins DJ, Peterson KE, Ferguson KK, Mercado-Garcia A, Tamayo YOM, Cantoral A et al. Relating phthalate and BPA exposure to metabolism in peripubescence: The role of exposure timing, sex, and puberty. J Clin EndocrinolMetab 2016; 101: 79-88.
8. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300: 1303-1310.
9. Shankar A, Teppala S, Sabanayagam C. Urinary bisphenol a levels and measures of obesity: results from the national health and nutrition examination survey 2003-2008. ISRN Endocrinol 2012; 2012: 965243.
10. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84: 319-327.
11. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 2009; 117: 1549-1555.
12. Liao C, Kannan K. A survey of bisphenol A and other bisphenol analogues in foodstuffs from nine cities in China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2014; 31: 319-329.
13. Rochester JR, Bolden AL. Bisphenol S and F: A systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect 2015; 123: 643-650.
14. Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB et al. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol 2012; 46: 6860-6866.
15. Zhou X, Kramer JP, Calafat AM, Ye X. Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 944: 152-156.
16. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006; 4: 263-273.
17. Koutnikova H, Cock TA, Watanabe M, Houten SM, Champy MF, Dierich A et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc Natl Acad Sci USA 2003; 100: 14457-14462.
18. Rosen ED. Molecular mechanisms of adipocyte differentiation. Ann Endocrinol (Paris) 2002; 63 (2 Pt 1): 79-82.
19. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ et al. C/EBPalpha induces adipogenesis through PPARgamma: A unified pathway. Genes Dev 2002; 16: 22-26.
20. Atlas E, Pope L, Wade MG, Kawata A, Boudreau A, Boucher JG. Bisphenol A increases aP2 expression in 3T3L1 by enhancing the transcriptional activity of nuclear receptors at the promoter. Adipocyte 2014; 3: 170-179.
21. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 2010; 18: 1283-1288.
22. Li X, Ycaza J, Blumberg B. The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. J Steroid Biochem Mol Biol 2011; 127: 9-15.
23. Greenspan P, Mayer EP, Fowler SD. Nile red: A selective fluorescent stain for intracellular lipid droplets. J Cell Biol 1985; 100: 965-973.
24. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998; 95: 4333-4337.
25. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P et al. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004; 145: 848-859.
26. Lea-Currie YR, Wen P, McIntosh MK. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1998; 248: 497-504.
27. Boucher JG, Boudreau A, Atlas E. Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogenreceptor antagonist. Nutr Diabetes 2014; 4: e102.
28. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro MC. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 2007; 21: 2185-2194.
29. Feve B, Antras J, Lasnier F, Hilliou F, Pairault J. The antiglucocorticoid RU38486 is a potent accelerator of adipose conversion of 3T3-F442A cells. Mol Cell Endocrinol 1989; 67: 17-27.
30. Helies-Toussaint C, Peyre L, Costanzo C, Chagnon MC, Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharmacol 2014; 280: 224-235.
31. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999; 4: 611-617.
32. Kroker AJ, Bruning JB. Review of the structural and dynamic mechanisms of PPARgamma partial agonism. PPAR Res 2015; 2015: 816856.
33. Bruning JB, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y et al. Partial agonists activate PPARgamma using a helix 12 independent mechanism. Structure 2007; 15: 1258-1271.
34. Kallenberger BC, Love JD, Chatterjee VK, Schwabe JW. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nat Struct Biol 2003; 10: 136-140.
35. Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A et al. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ Health Perspect 2011; 119: 1227-1232.
36. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991; 5: 1538-1552.
37. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000; 97: 12729-12734.
38. Joyner JM, Hutley LJ, Cameron DP. Glucocorticoid receptors in human preadipocytes: regional and gender differences. J Endocrinol 2000; 166: 145-152.
39. Yi KW, Shin JH, Seo HS, Lee JK, Oh MJ, Kim T et al. Role of estrogen receptor-alpha and-beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008; 16: 2393-2399.
40. Rosenmai AK, Dybdahl M, Pedersen M, Alice van Vugt-Lussenburg BM, Wedebye EB, Taxvig C et al. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci 2014; 139: 35-47.
41. Sharma G, Hu C, Brigman JL, Zhu G, Hathaway HJ, Prossnitz ER. GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology 2013; 154: 4136-4145.
42. Sharma G, Prossnitz ER. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 2011; 152: 3030-3039.
43. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008; 116: 1642-1647.
44. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 2009; 150: 1722-1730.
45. Martensson UE, Salehi SA, Windahl S, Gomez MF, Sward K, Daszkiewicz-Nilsson J et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiolstimulated insulin release in female mice. Endocrinology 2009; 150: 687-698.
46. Ijichi N, Ikeda K, Horie-Inoue K, Yagi K, Okazaki Y, Inoue S. Estrogen-related receptor alpha modulates the expression of adipogenesis-related genes during adipocyte differentiation. Biochem Biophys Res Commun 2007; 358: 813-818.
47. Cipelli R, Harries L, Okuda K, Yoshihara S, Melzer D, Galloway T. Bisphenol A modulates the metabolic regulator oestrogen-related receptor-alpha in T-cells. Reproduction 2014; 147: 419-426.
48. Rochester JR. Bisphenol A and human health: A review of the literature. Reprod Toxicol 2013; 42: 132-155.